Drugs / sa-mRNA vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06028347 | Oct 2023 → Oct 2024 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sa-mRNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06028347 ↗ |
| Modality | Messenger RNA (mRNA) | “self-amplifying mRNA vaccine” NCT06028347 ↗ |